Product Resource: Industry News

The custom technologies arm of Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, has partnered with the Discovery Technologies team at the Roche Innovation Center Basel of Pharma Research and Early Development (pRED) to develop a high-throughput detection system for drug discovery screens employing Roche’s proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF®) assays. The pRED screening teams in Basel and Shanghai are now installing the custom-developed Nano-TRF® cartridge in their existing Molecular Devices SpectraMax® Paradigm® multimode microplate readers and will receive on-demand delivery of new cartridges and continuing global technical support.

Crucial steps and surprising structures revealed in the genesis of the enzyme that divides the DNA double helix during cell replication.

Pity the poor lithium ion. Drawn relentlessly by its electrical charge, it surges from anode to cathode and back again, shouldering its way through an elaborate molecular obstacle course. This journey is essential to powering everything from cell phones to cordless power tools. Yet, no one really understands what goes on at the atomic scale as lithium ion batteries are used and recharged, over and over again.














